6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01767129 (ClinicalTrials.gov)	July 2013	9/1/2013	Safety and Efficacy of AVP-923in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease ...	A Phase 2a, Double-blind, Randomized, Placebo-controlled, Crossover Study to Evaluate the Safety and ...	Dyskinesia;Parkinson's Disease	Drug: AVP-923-45;Drug: Placebo	Avanir Pharmaceuticals	Michael J. Fox Foundation for Parkinson's Research	Completed	30 Years	80 Years	All	14	Phase 2	United States;Canada
2	NCT00056524 (ClinicalTrials.gov)	February 2003	15/3/2003	Safety Study of AVP-923in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Kno ...	An Open-Label Multicenter Study to Assess the Safety of AVP-923in the Treatment of Patients With Pse ...	Alzheimer's Disease;Stroke;Parkinson's Disease;Traumatic Brain Injury	Drug: AVP-923	Avanir Pharmaceuticals	NULL	Completed	18 Years	80 Years	Both	600	Phase 3	United States

First Previous1Next Last